Market Overview

Janney Capital Initiates Coverage on BioMarin Pharmaceutical Inc. at Buy, Announces $60.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BMRN

DateFirmActionFromTo
Jan 2016Credit SuisseInitiates Coverage onOutperform
Jan 2016BarclaysMaintainsOverweight
Nov 2015Goldman SachsInitiates Coverage onBuy

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (BMRN)

Get Benzinga's Newsletters